Integrated Surgical Tools for Prostate Neural Traffic Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The prevalence of pathologic diseases affecting the genitourinary tract, such as benign prostatic hyperplasia (BPH), chronic prostatitis (CP), hypogonadism, prostate cancer (PrCa), and erectile dysfunction (ED), increases with age, and existing pharmacologic interventions have limitations due to neuronal influences on urologic disease progression.

Innovation Solution

Systems and methods for monitoring and modulating electrophysiological activity within the prostate and testis using surgical tools with sensing and energy delivery elements, allowing for neuromodulation and targeted treatment of neural structures to regulate growth and function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If pharmacologic interventions are used to treat genitourinary diseases, then treatment effectiveness is improved, but limitations arise due to neuronal influences on disease progression

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidresponse to neuronal influences
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent introduces neuromodulation as an intermediary mechanism between the nervous system and genitourinary organs. By delivering electrical or magnetic stimuli to nerves (e.g., pelvic splanchnic nerves, hypogastric nerves) that innervate the prostate and other genitourinary organs, the system mediates therapeutic effects that pharmacologic agents cannot achieve alone, directly addressing the limitation of drug resistance to neuronal influences

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If surgical tools with sensing and energy delivery elements are used for neuromodulation, then precise regulation of neurological traffic is achieved, but device complexity increases

Engineering Contradiction:
Improveneurological traffic regulation precisionVSAvoidsurgical tool structure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple functional elements (sensing electrodes, energy delivery electrodes, imaging components) into a single integrated surgical tool or catheter assembly. This merging allows simultaneous monitoring of neurological activity and delivery of neuromodulation therapy through one device, achieving precise neurological regulation while reducing the number of separate procedures and devices needed

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The surgical tools incorporate sensing elements that provide real-time feedback on neurological traffic and organ response to neuromodulation. This feedback loop allows the system to adjust stimulation parameters dynamically, ensuring precise regulation of neurological activity while monitoring therapeutic effectiveness and minimizing side effects

Inventive Principle:
Principle #23Feedback

3Reliability

If targeted neuromodulation is applied to regulate organ growth and function, then therapeutic outcomes are enhanced, but collateral damage to surrounding tissues may occur

Engineering Contradiction:
Improvetherapeutic outcomeVSAvoidcollateral tissue damage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent employs targeted neuromodulation techniques that deliver electrical or magnetic stimuli specifically to identified nerve structures (e.g., pelvic splanchnic nerves, cavernous nerves) and their terminal fields in the prostate or other genitourinary organs. By focusing the neuromodulatory effect precisely at the nerve target and its specific innervation zone, the system enhances therapeutic outcomes while minimizing spread of energy to surrounding non-target tissues, thus reducing collateral damage

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20250325232A1Systems and methods for regulating organ and/or tumor growth rates, function, and/or development
Publication Date: 2025.10.23 AUTONOMIX MEDICAL INC
  • US20250325232A1 patent drawing
  • US20250325232A1 patent drawing
  • US20250325232A1 patent drawing

AI summary

A system for controlled neuromodulation procedures is disclosed. A system for controlled micro ablation procedures is disclosed. Systems and methods for imaging, monitoring, stimulating, and/or ablating neurological structures coupled to one or more organs of the lower urinary tract (LUT) are disclosed. Such processes may be used to alter the hormonal secretions from one or more organs, to modulate the growth of an organ, alter the growth rate or rate of perineural invasion of a tumor, or the like. In particular such processes may be used to slow, halt and/or reverse the growth of a prostate gland or a prostate tumor.